glp-1 management digital health startups Market Overview: Agonists and the Obesity Market | Blog glp-1 digital health platforms startups

A recent meta-analysis of mixed evidence (5 RCTs 52,183,184,185,186 and 1 cohort study 187 ) in 2,071 people with T2DM or Parkinsons disease suggested antidepressant efficacy of the GLP-1RAs exenatide and liraglutide over 2452 weeks 188

Consequently, resting heart rate may rise modestly

The company is also known for its metabolic psychiatry track, which includes primary care, psychiatric interventions, and dietitian expertise to tailor dietary and exercise programs for SMI care

Research from Levity, a digital health platform providing behavioral support and emotional tracking tools for people using GLP-1 medications, now shows that nearly one in three GLP-1 users admit to skipping or delaying a dose to avoid the logistics or embarrassment of traveling with injectables like Ozempic, Wegovy, or Mounjaro

Patients with individual or family histories of certain medical conditions, such as cancer-related risk factors, or multiple endocrine neoplasia syndrome type-2 (MEN 2) may be ineligible for tirzepatide treatment